Mydecine Innovations Group Inc.

MYCOF · OTC
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Operating Activities
Net Income-$13-$299$2,524
Dep. & Amort.$0$0$0
Deferred Tax$0$0$0
Stock-Based Comp.$0$0$0
Change in WC-$2$49$155
Other Non-Cash$5$259-$2,739
Operating Cash Flow-$10$10-$60
Investing Activities
PP&E Inv.$0$0$0
Net Acquisitions$0$0$0
Inv. Purchases$0$0$0
Inv. Sales/Matur.$0$0$0
Other Inv. Act.$0$0$0
Investing Cash Flow$0$0$0
Financing Activities
Debt Repay.$0$0$0
Stock Issued$0$0$0
Stock Repurch.$0$0$0
Dividends Paid$0$0$0
Other Fin. Act.$0$0$0
Financing Cash Flow$0$0$0
Forex Effect$0$0$0
Net Chg. in Cash-$10$10-$60
Supplemental Information
Beg. Cash$10$0$60
End Cash$0$10$0
Free Cash Flow-$10$10-$60